Acodis secures CHF 6 million

With the aim of helping businesses make better use of unstructured data from documents (PDF, word, scans, etc.), Acodis developed a no-code platform that allows business users to set up and customize AI models for any document type and in any language. The SaaS solution is trusted by the largest Pharma companies in the world that face ever-increasing regulatory, risk and compliance requirements.

In the last twelve months, Acodis reached significant milestones, including winning and onboarding three of the ten largest pharma companies to automate document processing at scale and launching a no-code platform for advanced document analysis and document-structure extraction. Among its customers are companies such as Allianz, Roche, Syngenta and Rhenus. Acodis is based in Winterthur with a team of 25 employees.

Closing a new financing round boosts the startup’s traction. Hi Inov, a European B2B venture capital fund and Swiss-VC firm VI Partners led the financing round. Olivier Laplace, Managing Partner at VI Partners, adds: “As part of their digital transformation efforts, corporate players need to streamline their document-intensive processes and unlock valuable information trapped inside documents. The market is gigantic. We have been excited by Acodis’ user-centric approach to building a platform for data extraction that enables companies to process complex and non-standard documents at speed and scale. We strongly believe that Acodis will become the Pharma and Health industry leader.”

Wolfgang Krause, Managing Partner at Hi Inov underlines: “Intelligent processing of complex documents is a fast-growing market. We are pleased to have found with Acodis a cutting-edge technology and an outstanding team with the potential to emerge as the leader in this space.”

(Press release/RAN)
Photo: Acodis Management team L-R: Patrick Emmisberger (CTO), Benjamin von Deschwanden (CPO), Martin Keller (CEO), Patrick Bürkle (CCO)